Susquehanna International Group, LLP Ac Immune Sa Call Options Transaction History

Susquehanna International Group, LLP

15 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$2.99 - $4.2 $79,235 - $111,300	-26,500 Reduced 17.68%	123,400 $466,000
Q2 2024 Aug 15, 2024	BUY	$2.29 - $4.87 $148,163 - $315,089	64,700 Added 75.94%	149,900 $598,000
Q1 2024 May 07, 2024	BUY	$2.66 - $4.87 $48,944 - $89,608	18,400 Added 27.54%	85,200 $252,000
Q4 2023 Feb 14, 2024	BUY	$2.46 - $5.0 $98,400 - $200,000	40,000 Added 149.25%	66,800 $334,000
Q3 2023 Nov 14, 2023	BUY	$2.77 - $3.38 $9,141 - $11,154	3,300 Added 14.04%	26,800 $76,000
Q2 2023 Aug 11, 2023	BUY	$1.85 - $3.4 $43,475 - $79,900	23,500 New	23,500 $69,000
Q3 2022 Nov 14, 2022	BUY	$2.4 - $3.64 $14,400 - $21,840	6,000 Added 36.36%	22,500 $71,000
Q2 2022 Aug 15, 2022	SELL	$2.35 - $4.47 $197,635 - $375,927	-84,100 Reduced 83.6%	16,500 $60,000
Q1 2022 May 16, 2022	BUY	$3.5 - $5.16 $295,050 - $434,988	84,300 Added 517.18%	100,600 $402,000
Q4 2021 Feb 14, 2022	SELL	$4.83 - $7.56 $744,786 - $1.17 Million	-154,200 Reduced 90.44%	16,300 $81,000
Q3 2021 Nov 15, 2021	SELL	$6.2 - $8.34 $146,320 - $196,824	-23,600 Reduced 12.16%	170,500 $1.14 Million
Q2 2021 Aug 11, 2021	BUY	$6.04 - $8.37 $126,236 - $174,932	20,900 Added 12.07%	194,100 $1.54 Million
Q1 2021 May 17, 2021	BUY	$5.32 - $8.96 $60,116 - $101,248	11,300 Added 6.98%	173,200 $1.32 Million
Q4 2020 Feb 16, 2021	BUY	$4.47 - $5.58 $286,974 - $358,236	64,200 Added 65.71%	161,900 $837,000
Q3 2020 Nov 16, 2020	BUY	$4.78 - $9.06 $467,006 - $885,162	97,700 New	97,700 $477,000

28.2M

150K

12.4K

Ticker ACIU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,413,504
Market Cap $296M
Description
AC Immune SA, a clinical stage biopharmaceutical company, discovers, designs, and develops medicines and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding. Its SupraAntigen and Morphomer platforms are designed to generate vaccines, antibodies, and small molecules, which selectiv...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.